KRMD vs. KIDS, NPCE, SMLR, TMCI, CLPT, OM, NNOX, NYXH, SMTI, and ZIMV
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include OrthoPediatrics (KIDS), NeuroPace (NPCE), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Outset Medical (OM), Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry.
KORU Medical Systems vs. Its Competitors
OrthoPediatrics (NASDAQ:KIDS) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.
In the previous week, OrthoPediatrics and OrthoPediatrics both had 3 articles in the media. OrthoPediatrics' average media sentiment score of 1.03 beat KORU Medical Systems' score of 0.82 indicating that OrthoPediatrics is being referred to more favorably in the media.
KORU Medical Systems has lower revenue, but higher earnings than OrthoPediatrics. KORU Medical Systems is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.
OrthoPediatrics has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.
69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by company insiders. Comparatively, 20.6% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
OrthoPediatrics received 272 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 64.43% of users gave OrthoPediatrics an outperform vote while only 63.38% of users gave KORU Medical Systems an outperform vote.
OrthoPediatrics has a net margin of -15.00% compared to KORU Medical Systems' net margin of -37.42%. OrthoPediatrics' return on equity of -5.78% beat KORU Medical Systems' return on equity.
OrthoPediatrics currently has a consensus price target of $35.83, indicating a potential upside of 69.34%. KORU Medical Systems has a consensus price target of $4.50, indicating a potential upside of 39.32%. Given OrthoPediatrics' higher possible upside, equities analysts clearly believe OrthoPediatrics is more favorable than KORU Medical Systems.
Summary
OrthoPediatrics beats KORU Medical Systems on 12 of the 18 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
This page (NASDAQ:KRMD) was last updated on 6/14/2025 by MarketBeat.com Staff
Buy KRMD Stock Free KRMD Stock Alerts